Chemoresistance is an important cause of treatment failure in bladder cancer, and
identifying genes that confer drug resistance is an important step toward developing new …

Objective The aim of this review is to summarize the current evidence and future
perspectives of bladder-sparing treatment for MIBC. Methods A non-systematic literature …

Simple Summary Understanding how effective a treatment is before a major bladder surgery
can help doctors to plan better patient care. Our research investigated the survival rates of …

Background: Neutrophil-to-lymphocyte ratio (NLR), a widely assessed biomarker in most
common diseases, is typically evaluated before treatment initiation. However, data on NLR …

Objetivo Esta revisión tiene como objetivo resumir la evidencia actual y las perspectivas
futuras del tratamiento conservador de la vejiga para MIBC. Métodos En octubre de 2023 se …

In 2020, an estimated 212,536 bladder cancer-related deaths and 573,238 new cases of
bladder cancer were reported worldwide. 1 Neoadjuvant chemotherapy (NAC) followed by …

Background: Bladder only radiotherapy (RT) concurrent with chemotherapy emerged as a
valid treatment option for patients with muscle invasive bladder cancer (MIIBC) with …